Article
AI-focused Biopharma Partnerships Drive Transformation of R&D
Mar 27, 2023

The application of artificial intelligence and machine learning (AI/ML) has quickly gained momentum within the pharmaceutical industry as it holds the potential to transform the drug discovery and development process. The number of partnering deals utilizing AI/ML within the field is now at its highest in 5 years, as companies are willing to commit significant valuations to these tools for a variety of therapy areas. Showing no signs of abating, partnering activity is likely to remain strong as key players look to expand and optimize their R&D efforts.

Please fill in your details on the left to download the article.

Related solutions

Contact Us